Skip to main content
. 2015 Nov 27;23(3):177–181. doi: 10.1136/ejhpharm-2015-000718

Table 1.

Demographic characteristics

Characteristic Patients exposed to intervention (N= 49) Control group (N=50) Difference between exposed and control groups
Gender Female 12 12 χ2=0.003, p=0.955
Male 37 38
Age (years), mean±SD (range) 54.9±9.5 (33–88) 54.8±11.9 (32–88) T=0.010, p=0.992
Age categories (years) 30–40 3 5 χ2=7.708, p=0.103
41–50 8 16
51–60 24 12
61–70 13 13
71–90 1 4
Diagnosis F20 46 45 χ2=6.002, p=0.423
F22 1 1
F29 1 1
F23, F25 F33 1 3
Duration of disease (years), mean±SD (range) 21.5±10.9 (1.0–44.0) 18.4±10.2 (1.0–45.0) T=-1.466, p=0.146
Duration of hospitalisation (years), mean±SD (range) 12.1±9.0 (1.0–42.0) 10.9±9.7 (1.0–45.0) T=-0.617, p=0.539
Hospitalisation (number of patients) Dismissed at weekends 11 13 χ2=0.170, p=0.680
Continuous 38 37
Number of prescribed drugs per patient, mean±SD (range) Before the intervention 4.2±1.5 (2–8) 4.0±0.9 (2–8) T=-0.828, p=0.410
After the intervention 3.4±1.6 (0–7) 3.9±0.9 (2–8) T=-1.017, p=0.312
Difference before/after Tpaired=-3.263, p=0.002* Tpaired=-1.003, p=0.320

*Significant difference.